Marijuana
CBD Is Flexing on the Marijuana Industry
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
Cronos Group Could Break Key Moving Averages - Protect Long Positions
Let's look at the chart of CRON.
OrganiGram Could Climb Higher, but You Need Discipline Before Buying
Here's how to play OGI stock right now.
Prohibition and the Paradoxical Proclivity of Cannabis Consumption
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Not High on Canopy Growth's Earnings? Take a Deeper Look
At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.
Should Investors Buy the Dip in Canopy Growth Stock?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
Canopy Growth Slips as Production, Margins Disappoint
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
Beyond Meat Went Beyond Logic, and Now It's Beyond Trading
There's no way to play the stock of the meat alternative provider unless you are a kamikaze daredevil with a very deep pocketbook.
Checking Back With Tesla and Alphabet, and Checking Out 2 Other Names
Besides revisiting the first two companies, we also look at trade setups for Canopy Growth and Nike.